Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1127-1133

  Leibovici, Leonard ^a   Paul, Michal ^b   Poznanski, Oded ^b   Drucker, Moshe ^b   Samra, Zmira ^b   Konigsberger, Hanna ^b   Pitlik, Silvio D ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b Beilinson Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; UREIDOPENICILLIN;

ADULT; AGED; ARTICLE; BACTEREMIA; DRUG EFFICACY; DRUG MIXTURE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0030970810     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1127     Document Type: Article

References (18)

1. Bodey, G. P., L. Jadeja, and L. Elting. 1985. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch. Intern. Med. 145:1621-1629.
2. Bryan, C. S., K. L. Reynolds, and E. R. Brenner. 1983. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev. Infect. Dis. 5:629-638.
3. The EORTC International Antimicrobial Therapy Cooperative Group. 1987. Ceftazidime combined with short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N. Engl. J. Med. 317:1692-1698.
4. Extermann, M., and C. Regamey. 1994. Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agents or combination therapy? Infection 22:5-7.
5. Fainstein, V., G. P. Bodey, L. Elting, et al. 1983. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J. Antimicrob. Chemother. 12(Suppl. A):101-110.
6. Geerdes, H. F., D. Ziegler, H. Lode, et al. 1992. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin. Infect. Dis. 15:991-1002.
7. Giamarellou, H. 1985. Aminoglycosides plus β-lactams against gram-negative organisms: evaluation of in-vitro synergy and chemical interactions. Am. J. Med. 80(Suppl. B):126-137.
8. Giamarellou, H., P. Zissis, G. Tagari, and J. Bouzos. 1984. In vitro synergistic activities of aminoglycosides and new beta-lactams against multi-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 25:534-536.
9. Gransden, W. R., L. Leibovici, S. J. Eykyn, et al. 1996. Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteraemia. J. Clin. Microbiol. Infect. 1:119-123.
10. Hilf, M., V. L. Yu, J. Sharp, et al. 1987. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. 83:65-71.
11. Hoepelman, I. M., M. Rozenberg-Arske, and J. Verhoef. 1988. Comparison of once-daily ceftriaxone with gentamycin plus cefuroxime for treatment of serious bacterial infections. Lancet i:1305-1309.
12. Koren, G., J. Klein, and S. M. MacLeod. 1988. The dissociation between aminoglycoside serum concentrations and nephrotoxicity. Life Sci. 43:1817-1823.
13. Korvick, J. A., C. S. Bryan, B. Farber, T. R. Beam, Jr., L. Schenfeld, R. R. Muder, D. Weinbaum, R. Lumish, D. N. Gerding, M. M. Wagener, and V. L. Yu. 1992. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob. Agents Chemother. 36:2639-2644.
14. Krogstad, D. J., and R. C. Moellering. 1980. Antimicrobial combinations, p. 298-341. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
15. Lancet. 1992. Cross design synthesis: a new strategy for studying medical outcomes? Lancet 340:944-946. (Editorial.)
16. Leibovici, L., Z. Samra, H. Konigsbereger, M. Drucker, S. Ashkenazi, and S. D. Pitlik. 1995. Long-term survival following bacteremia or fungemia. JAMA 274:807-812.
17. Perl, T. M., M. Dvorak, T. Hwang, and R. P. Wenzel. 1995. Long-term survival and function after suspected gram-negative sepsis. JAMA 274:338-345.
18. Piccart, M., J. Klastersky, F. Meunier, H. Lagast, Y. van Laethem, and D. Weerts. 1984. Single-drug versus combination empirical treatment for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrob. Agents Chemother. 26:870-875.